Our Featured Experts

Julie R. Gralow, MD
Dr. Gralow Discusses Toxicities Observed in the SWOG S0307 Trial
Julie R. Gralow, MD, director, Breast Medical Oncology, Seattle Cancer Care Alliance, clinical research division, member, Fred Hutchinson Cancer Care Center, professor, Medical Oncology Division, University of Washington School of Medicine, discusses toxicities observed in the SWOG S0307 trial, which examined bisphosphonates as adjuvant therapy in primary breast cancer.
Michael J. Morris, MD
Oncology Specialists
Publication Bottom Border
Border Publication
x